Clinical trial for Obesity
Official title Body Composition and Exercise to Prevent Muscle Loss With GLP1 Agonist Treatment
ClinicalTrials.gov ID: NCT07226947
What this study is testing
- What it's testing
- This study aims to find out if using a smartwatch to track activity and body changes, along with exercise reminders, can safely help maintain strength and muscle mass.
- Who it's for
- The study is looking for people with obesity who have recently started or are planning to start treatment with weight-loss medications like semaglutide or tirzepatide.
- What's involved
- Participants will use a smartwatch to measure their activity level and body composition and will receive reminders to exercise.
- Time commitment
- The source text does not specify the duration of the study or the number of visits required.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 99
You may be able to join if
- Age ≥ 18 years old at time of signing informed consent
- Started treatment with incretin therapy (liraglutide, semaglutide, tirzepatide, or retatrutide) within the past 2 months or planning to start this...
- Able to provide informed consent
You likely can't join if
- Current pregnancy (positive urine hCG) or plans to become pregnant in the next 6 months
- BMI \<25 kg/m2 at the time of screening
- Unable to participate in a regular physical exercise program
- Implanted pacemaker
- Any factors that, in the opinion of the principal investigator, would interfere with the safe completion of the study
The study team makes the final eligibility decision.
Where it is enrolling
- Boston, Massachusetts, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 99 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Boston, Massachusetts, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.